Virosomes in vaccine development: induction of cytotoxic T lymphocyte activity with virosome-encapsulated protein antigens.
about
Safety and efficacy of influenza vaccination in systemic lupus erythematosus patients with quiescent disease.Influenza: current evidence and informed predictions.Influenza vaccination in the elderly: seeking new correlates of protection and improved vaccines.The virosomal adjuvanted influenza vaccine.T cell responses to viral infections - opportunities for Peptide vaccination.Mechanisms of action of adjuvantsInfluenza virosomes as an efficient system for adjuvanted vaccine delivery.
P2860
Q35637308-C6635F27-EA64-4F37-A534-300B98745D90Q35843644-917BDF73-09F5-405A-9090-FA53A7D4DC5DQ37655007-5C9F7B4A-A472-4CED-BD6C-3D10220F1F4EQ37678409-49DCFA34-2B18-4386-9917-425BEE81084BQ37718978-AC299C47-A54C-4FD5-AE59-8B3C8E0FA18EQ38110539-7BCB76AF-6FF7-4705-91D5-678FBBEEAAB7Q47989318-0D0F3602-0B25-4419-9CFF-136B8D8460DB
P2860
Virosomes in vaccine development: induction of cytotoxic T lymphocyte activity with virosome-encapsulated protein antigens.
description
2002 nî lūn-bûn
@nan
2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Virosomes in vaccine developme ...... encapsulated protein antigens.
@ast
Virosomes in vaccine developme ...... encapsulated protein antigens.
@en
type
label
Virosomes in vaccine developme ...... encapsulated protein antigens.
@ast
Virosomes in vaccine developme ...... encapsulated protein antigens.
@en
prefLabel
Virosomes in vaccine developme ...... encapsulated protein antigens.
@ast
Virosomes in vaccine developme ...... encapsulated protein antigens.
@en
P50
P356
P1476
Virosomes in vaccine developme ...... encapsulated protein antigens.
@en
P2093
Laura Bungener
Wouter ter Veer
P304
P356
10.1081/LPR-120004789
P577
2002-02-01T00:00:00Z